Table 4 Results in the adjuvant chemoradiotherapy treatment arms of selected studies on patients with gastric cancer undergoing surgery and D2 lymph node dissection
Author (year) | Median no. of PLNs a /percentage of patients with stage III or IV (M0) a | Regimen/technique | End point |
---|---|---|---|
5.5/63 | S-1+45 Gy/AP-PA | 3-year DFS 65.2%, OS 76.1% | |
8/100 | FL+45 Gy/AP-PA | 5-year DFS 60.9%, OS 65.2% | |
NM/71.2 | FL+45 Gy/IMRT | 5-year DFS 45.2%, OS 48.4% | |
ARTIST (2012) | 3/42.1 | Capecitabine+45 Gy/AP-PA | 3-year DFS 78.2%, |